Cynosure Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,682	Closed	-$347K	–	115
2018 Q2	$347K	Hold	2,682	–	–	0.09%	167
2018 Q1	$276K	Buy	+2,682	New	+$276K	0.07%	192